Abstract: The present invention provides novel heterocylic amide compounds having useful antimycobacterial activity. Use of these compounds as pharmaceutical compositions and method of their production are also provided.
Type:
Grant
Filed:
February 28, 2019
Date of Patent:
May 23, 2023
Assignee:
CRESTONE, INC.
Inventors:
Joshua Day, James Graham, Thale Jarvis, Elizabeth Mcfaddin, Urs Ochsner, Xicheng Sun, Christina Wong
Abstract: Novel bicyclic heteroaromatic compounds are provided that are inhibitors of bacterial methionyl tRNA synthetase (MetRS). Compounds of the invention generally have a left hand side phenylether constituent and a right hand side thienopyridone constituent. Also disclosed are methods for their preparation and their use in therapy as antibacterial agents, particularly as anti-Clostridium difficile agents.
Type:
Grant
Filed:
September 11, 2007
Date of Patent:
April 15, 2014
Assignee:
Crestone, Inc.
Inventors:
Joseph Guiles, Xicheng Sun, Nebojsa Janjic, Sarah Strong
Abstract: The present invention provides novel sulfone and sulfoxide substituted heterocyclic urea compounds having useful antibacterial activity. Use of these compounds as pharmaceutical compositions and methods of production are provided.
Type:
Grant
Filed:
July 23, 2008
Date of Patent:
October 23, 2012
Assignee:
Crestone, Inc.
Inventors:
Joseph Guiles, Thale Jarvis, Sarah Strong, Xicheng Sun, Jian Qiu, John C. Rohloff
Abstract: The present invention provides novel amide and sulfonamide substituted heterocyclic urea compounds having useful antibacterial activity. Use of these compounds as pharmaceutical compositions and method of their production are also provided.
Type:
Grant
Filed:
July 23, 2008
Date of Patent:
April 3, 2012
Assignee:
Crestone, Inc.
Inventors:
Joseph Guiles, Thale Jarvis, Sarah Strong, Xicheng Sun, Jian Qiu, John C. Rohloff
Abstract: The present invention provides novel amide and sulfonamide substituted heterocyclic urea compounds having useful antibacterial activity. Use of these compounds as pharmaceutical compositions and method of their production are also provided.
Type:
Application
Filed:
July 23, 2008
Publication date:
January 19, 2012
Applicant:
CRESTONE, INC.
Inventors:
Joseph Guiles, Thale Jarvis, Sarah Strong, Xicheng Sun, Jian Qiu, John C. Rohloff
Abstract: Novel bicyclic heteroaromatic compounds are provided that are inhibitors of bacterial methionyl tRNA synthetase (MetRS). Compounds of the invention generally have a left hand side chroman group or left hand side tetrahydroquinoline group and a right hand side thienopyridone group. Also disclosed are methods for their preparation and their use in therapy as antibacterial agents, particularly as anti-Clostridium difficile agents.
Type:
Grant
Filed:
September 11, 2007
Date of Patent:
August 9, 2011
Assignee:
Crestone, Inc.
Inventors:
Joseph Guiles, Xicheng Sun, Nebojsa Janjic, Sarah Strong
Abstract: Novel compounds in enantiomeric excess that are inhibitors of bacterial methionyl synthetase (MetRS) are disclosed. Also disclosed are methods for their preparation and their use in therapy as antibacterial agents, and in particular their use in therapy for Clostridium difficile infection.
Type:
Grant
Filed:
September 11, 2007
Date of Patent:
July 5, 2011
Assignee:
Crestone, Inc.
Inventors:
Joseph Guiles, Xicheng Sun, Nebojsa Janjic, Sarah Strong, Albert Charles Gyorkos
Abstract: The present invention provides novel sulfone and sulfoxide substituted heterocyclic urea compounds having useful antibacterial activity. Use of these compounds as pharmaceutical compositions and methods of production are provided.
Type:
Application
Filed:
July 23, 2008
Publication date:
November 11, 2010
Applicant:
CRESTONE, INC.
Inventors:
Joseph Guiles, Thale Jarvis, Sarah Strong, Xicheng Sun, Jian Qiu, John C. Rohloff